Search research articles
Contact Us
Filters
Showing results (1-10 of 10) with videos related to
Page
of 1
Sort By:
Methods in Molecular Biology (Clifton, N.J.)
|
November 6, 2010
Intracellular delivery of nanoparticles with CPPs
Rupa Sawant, Vladimir Torchilin
Molecular Biosystems
|
March 19, 2010
Intracellular transduction using cell-penetrating peptides
Rupa Sawant, Vladimir Torchilin
Advanced Drug Delivery Reviews
|
September 12, 2012
Immunoconjugates and long circulating systems: origins, current state of the art and future directions
Alexander Koshkaryev, Rupa Sawant, Madhura Deshpande, et al.
Bioconjugate Chemistry
|
July 16, 2009
TAT peptide and its conjugates: proteolytic stability
Jacob Grunwald, Tomas Rejtar, Rupa Sawant, et al.
Acta Biomaterialia
|
April 13, 2017
PEG-PE/clay composite carriers for doxorubicin: Effect of composite structure on release, cell interaction and cytotoxicity
Hagay Kohay, Can Sarisozen, Rupa Sawant, et al.
Pharmaceutical Research
|
February 14, 2014
Novel nanostructured lipid carrier co-loaded with doxorubicin and docosahexaenoic acid demonstrates enhanced in vitro activity and overcomes drug resistance in MCF-7/Adr cells
Samuel V Mussi, Rupa Sawant, Federico Perche, et al.
Journal of Biophotonics
|
August 21, 2012
Synergy of photoacoustic and fluorescence flow cytometry of circulating cells with negative and positive contrasts
Dmitry A Nedosekin, Mustafa Sarimollaoglu, Ekaterina I Galanzha, et al.
Journal of Controlled Release : Official Journal of the Controlled Release Society
|
October 26, 2011
Liposome based systems for systemic siRNA delivery: stability in blood sets the requirements for optimal carrier design
Kevin Buyens, Stefaan C De Smedt, Kevin Braeckmans, et al.
Journal of Medicinal Chemistry
|
August 20, 2025
Discovery of Selective and Orally Bioavailable Heterobifunctional Degraders of Cyclin-Dependent Kinase 2
Philip N Collier, Xiaozhang Zheng, Melissa Ford, et al.
Frontiers in Immunology
|
January 30, 2026
Targeted degradation of MK2 is insufficient to block inflammatory cytokine production in human cells due to cooperativity with MK3 and MK5
Bin Yang, Guoqiang Fang, Isaac Marx, et al.
Page
of 1
Search research articles
Search
Showing results (1-10 of 10) with videos related to
Sort By:
Page
of 1
Methods in Molecular Biology (Clifton, N.J.)
|
November 6, 2010
Intracellular delivery of nanoparticles with CPPs
Rupa Sawant, Vladimir Torchilin
Molecular Biosystems
|
March 19, 2010
Intracellular transduction using cell-penetrating peptides
Rupa Sawant, Vladimir Torchilin
Advanced Drug Delivery Reviews
|
September 12, 2012
Immunoconjugates and long circulating systems: origins, current state of the art and future directions
Alexander Koshkaryev, Rupa Sawant, Madhura Deshpande, et al.
Bioconjugate Chemistry
|
July 16, 2009
TAT peptide and its conjugates: proteolytic stability
Jacob Grunwald, Tomas Rejtar, Rupa Sawant, et al.
Acta Biomaterialia
|
April 13, 2017
PEG-PE/clay composite carriers for doxorubicin: Effect of composite structure on release, cell interaction and cytotoxicity
Hagay Kohay, Can Sarisozen, Rupa Sawant, et al.
Pharmaceutical Research
|
February 14, 2014
Novel nanostructured lipid carrier co-loaded with doxorubicin and docosahexaenoic acid demonstrates enhanced in vitro activity and overcomes drug resistance in MCF-7/Adr cells
Samuel V Mussi, Rupa Sawant, Federico Perche, et al.
Journal of Biophotonics
|
August 21, 2012
Synergy of photoacoustic and fluorescence flow cytometry of circulating cells with negative and positive contrasts
Dmitry A Nedosekin, Mustafa Sarimollaoglu, Ekaterina I Galanzha, et al.
Journal of Controlled Release : Official Journal of the Controlled Release Society
|
October 26, 2011
Liposome based systems for systemic siRNA delivery: stability in blood sets the requirements for optimal carrier design
Kevin Buyens, Stefaan C De Smedt, Kevin Braeckmans, et al.
Journal of Medicinal Chemistry
|
August 20, 2025
Discovery of Selective and Orally Bioavailable Heterobifunctional Degraders of Cyclin-Dependent Kinase 2
Philip N Collier, Xiaozhang Zheng, Melissa Ford, et al.
Frontiers in Immunology
|
January 30, 2026
Targeted degradation of MK2 is insufficient to block inflammatory cytokine production in human cells due to cooperativity with MK3 and MK5
Bin Yang, Guoqiang Fang, Isaac Marx, et al.
Page
of 1